It has been demonstrated that exosome-derived epidermal growth factor receptor (EGFR) protein in lung cancer cells induces the formation of tolerogenic dendritic cells (DCs), which in turn inhibits the anti-cancer effects of CD8+ T cells by inducing the production of regulatory T cells (Treg), and ultimately Treg promotes cancer immune escape (58). Here, EGFR is linked to lung cancer.